Welcome to CEVHAP

Welcome to CEVHAP

The Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) was established in October 2010 as a multidisciplinary body to advocate for public policy reforms that reduce the burden of viral hepatitis in Asia-Pacific.

CEVHAP is the first organisation based in the Asia Pacific region to dedicate its efforts to this cause.

The organisation is committed to building partnerships with others who share the same goals including: governments, NGOs, the business sector, academic researchers, civil society and people themselves who are infected.

Viral hepatitis - It's closer than you think. One million people die from viral hepatitis in Asia Pacific every year.  On WORLD HEPATITIS DAY CEVHAP urges governments to embrace WHO’s new Global Framework for Action.             >> READ MORE
FaLang translation system by Faboba
Connect with us     connect with CEVHAP           

CAF badge

CEVHAP has been vetted and approved to receive tax-deductible donations and grants via CAF America.

If you are a US donor wishing to make a tax-deductible contribution to support us, please visit the “Give Now” page at CAF America’s website at www.cafamerica.org and following these steps:

1. Visit http://cafamerica.org

2. Click “Give Now”

3. “Give a single gift”

4. “Search and Give to organizations in the CAF America Database”

5. Type in “CEVHAP”

6. Click “Donate Now”

7. Fill out the form accordingly and click Submit

8. Enter credit card information and click Submit

9. Wait for the confirmation page – do not re-click submit or refresh the page as you may be additionally charged.

10. An e-mail confirmation will be sent to you for tax deduction purposes.


CEVHAP Activity Report Brochure EMAIL smaller Cover

Viral Hepatitis
  Globally, 2 billion people have been
infected with hepatitis B virus, with an
estimated 600,000 dying each year . . .
  The number of people with chronic
hepatitis C and more advanced liver
disease or cirrhosis, is projected to
increase by 38% between 2006 and 2015
unless the number of people being
treated increases substantially.
  There is no vaccine for hepatitis C but
approximately 80% of patients who are
able to complete recommended
treatment, are cured . . .
Why hepatitis policy matters - the story of Baltazar Lucas  
Video What are the dangers of viral #hepatitis? Hear what #CEVHAP Chair Prof Ding-Shinn Chen had to say to the Wall Street Journal.
A Message from DS Chen
Chairman, CEVHAP